UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer

Frontiers in genetics, 2020-03, Vol.11, p.237-237

2020

Volltextzugriff (PDF)

Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231169981-17588359231169981

2023

Volltextzugriff (PDF)

Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma

Frontiers in oncology, 2022-10, Vol.12, p.1003845-1003845

2022

Volltextzugriff (PDF)

Case Report: A case of advanced duodenal adenocarcinoma in complete remission after chemotherapy combined with targeted therapy and radiotherapy

Frontiers in oncology, 2022-10, Vol.12

2022

Volltextzugriff (PDF)

Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells

PloS one, 2012-12, Vol.7 (12), p.e50956

2012

Volltextzugriff (PDF)

Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer

BMC cancer, 2023-03, Vol.23 (1), p.227-227, Article 227

2023

Volltextzugriff (PDF)

Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway

Biomedicine & pharmacotherapy, 2019-01, Vol.109, p.563-572

2019

Volltextzugriff (PDF)

STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer

Clinical science (1979), 2019-03, Vol.133 (5), p.645-663

2019

Volltextzugriff (PDF)

Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti-PD-1 Therapy

Frontiers in cell and developmental biology, 2021-03, Vol.9, p.638312-638312

2021

Volltextzugriff (PDF)

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors

Cancer medicine (Malden, MA), 2023-07, Vol.12 (14), p.15217-15228

2023

Volltextzugriff (PDF)

AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells

Biochemical and biophysical research communications, 2009-03, Vol.380 (3), p.699-704

2009

Volltextzugriff (PDF)

Expression of phosphorylated Stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma

International journal of colorectal disease, 2011, Vol.26 (1), p.29-35

2011

Volltextzugriff (PDF)

LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP‐mediated pathway

Journal of cellular physiology, 2020-04, Vol.235 (4), p.3928-3938

2020

Volltextzugriff (PDF)

Recent advances in natural polysaccharides against hepatocellular carcinoma: A review

International journal of biological macromolecules, 2023-12, Vol.253, p.126766-126766, Article 126766

2023

Volltextzugriff (PDF)

Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score

Cancer Immunology, Immunotherapy, 2023-11, Vol.72 (11), p.3635-3649

2023

Volltextzugriff (PDF)

HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis

Cancer letters, 2022-05, Vol.533, p.215595-215595, Article 215595

2022

Volltextzugriff (PDF)

Self-programmed dynamics of T cell receptor condensation

Proceedings of the National Academy of Sciences - PNAS, 2023-07, Vol.120 (28), p.e2217301120-e2217301120

2023

Volltextzugriff (PDF)

Camrelizumab combined with ablation and chemotherapy for pancreatic cancer with liver metastases: A single-arm, phase II, prospective clinical study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS4169-TPS4169

2021

Volltextzugriff (PDF)

Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma

The oncologist (Dayton, Ohio), 2024-09

2024

Volltextzugriff (PDF)

Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer

Pathology, research and practice, 2019-06, Vol.215 (6), p.152383-152383, Article 152383

2019

Volltextzugriff (PDF)

TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma

Histopathology, 2014-10, Vol.65 (4), p.517-526

2014

Volltextzugriff (PDF)

CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis

Cancer biology & therapy, 2019-09, Vol.20 (9), p.1290-1299

2019

Volltextzugriff (PDF)

A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer

Medical science monitor, 2020-10, Vol.26, p.e927654-e927654

2020

Volltextzugriff (PDF)

Efficacy observation of albumin-bound paclitaxel combined with S1, sequential and alternate gemcitabine combined with oxaliplatin in the first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): A single-arm, prospective study

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.409-409

2021

Volltextzugriff (PDF)

Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer

Journal of Cancer, 2022, Vol.13 (1), p.225-242

2022

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)
Berichte
(1)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer

Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma

Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma

Case Report: A case of advanced duodenal adenocarcinoma in complete remission after chemotherapy combined with targeted therapy and radiotherapy

Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells

Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer

Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway

STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer

Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti-PD-1 Therapy

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors

AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells

Expression of phosphorylated Stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma

LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP‐mediated pathway

Recent advances in natural polysaccharides against hepatocellular carcinoma: A review

Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score

HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis

Self-programmed dynamics of T cell receptor condensation

Camrelizumab combined with ablation and chemotherapy for pancreatic cancer with liver metastases: A single-arm, phase II, prospective clinical study

Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma

Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer

TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma

CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis

A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer

Efficacy observation of albumin-bound paclitaxel combined with S1, sequential and alternate gemcitabine combined with oxaliplatin in the first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): A single-arm, prospective study

Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer

Suchergebnisse filtern